Together, these effects may help explain trends observed in recent studies examining GLP-1 therapies and CKD progression
A 14.9% reduction in body weight has the potential to improve, prevent, or possibly reverse certain disease processes
Many insurance providers, including UnitedHealthcare and Blue Cross Blue Shield, provide coverage if the prescription is for medically-documented obesity or overweight conditions
Our weight loss clinicians will recommend the most suitable dose for you
Semaglutide treatment, an FDA-approved approach, has been helping countless adults achieve significant and lasting weight loss while improving overall health
Brain Sci 14:617 Badulescu S, Tabassum A, Le GH et al (2024) Glucagon-like peptide 1 agonist and effects on reward behaviour: a systematic review